High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis


A recently published study by Tseng et.al. (1) named "High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis" came to following results:

    • High-dosage omega-3 fatty acids significantly outperformed most pharmacological options in reducing migraine frequency and severity.
    • The effect was particularly pronounced in chronic migraine sufferers.
    • Omega-3 fatty acids exhibited fewer adverse effects compared to traditional pharmacological treatments, making them a safer long-term option for patients.
    • The proposed mechanisms include anti-inflammatory effects and modulation of neuronal excitability, which are thought to reduce migraine triggers.
    • Effective doses ranged from 2-3 grams per day of omega-3 fatty acids, with higher doses providing superior results.

Conclusion:
2-3 grams per day omega-3 fatty acids are an effective and safer alternative to existing pharmacological treatments for migraine prophylaxis. Their use may be particularly beneficial for patients who are intolerant to traditional medications or seek non-pharmacological approaches.

Implications for Practice:
The findings support the incorporation of omega-3 supplementation into migraine management guidelines, emphasizing personalized approaches based on patient preferences and tolerances.

Citation:
Tseng PT, et al. Adv Nutr. 2024;15(2):100163. doi: 10.1016/j.advnut.2023.100163. Epub 2023 Dec 16.